Wuhan Hvsen (China) Performance
| 300871 Stock | 10.37 0.04 0.39% |
The firm maintains a market beta of 0.0646, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Wuhan Hvsen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Wuhan Hvsen is expected to be smaller as well. At this point, Wuhan Hvsen Biotechnology has a negative expected return of -0.0605%. Please make sure to check out Wuhan Hvsen's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Wuhan Hvsen Biotechnology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Wuhan Hvsen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Wuhan Hvsen is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Forward Dividend Yield 0.026 | Payout Ratio 1.2068 | Last Split Factor 1.5:1 | Forward Dividend Rate 0.27 | Ex Dividend Date 2024-05-29 |
| Begin Period Cash Flow | 278.6 M |
Wuhan |
Wuhan Hvsen Relative Risk vs. Return Landscape
If you would invest 1,100 in Wuhan Hvsen Biotechnology on November 3, 2024 and sell it today you would lose (63.00) from holding Wuhan Hvsen Biotechnology or give up 5.73% of portfolio value over 90 days. Wuhan Hvsen Biotechnology is generating negative expected returns and assumes 2.7075% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than Wuhan, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Wuhan Hvsen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Wuhan Hvsen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Wuhan Hvsen Biotechnology, and traders can use it to determine the average amount a Wuhan Hvsen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0224
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 300871 |
Estimated Market Risk
| 2.71 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Wuhan Hvsen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wuhan Hvsen by adding Wuhan Hvsen to a well-diversified portfolio.
Wuhan Hvsen Fundamentals Growth
Wuhan Stock prices reflect investors' perceptions of the future prospects and financial health of Wuhan Hvsen, and Wuhan Hvsen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wuhan Stock performance.
| Return On Equity | -0.0312 | ||||
| Return On Asset | -0.0029 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.16 B | ||||
| Shares Outstanding | 165.77 M | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 1.53 X | ||||
| Revenue | 1.02 B | ||||
| Gross Profit | 193.53 M | ||||
| EBITDA | 150.08 M | ||||
| Net Income | 16.78 M | ||||
| Total Debt | 240.32 M | ||||
| Book Value Per Share | 8.62 X | ||||
| Cash Flow From Operations | 92.92 M | ||||
| Earnings Per Share | (0.28) X | ||||
| Total Asset | 2.98 B | ||||
| Retained Earnings | 341.94 M | ||||
About Wuhan Hvsen Performance
By analyzing Wuhan Hvsen's fundamental ratios, stakeholders can gain valuable insights into Wuhan Hvsen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Wuhan Hvsen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Wuhan Hvsen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Wuhan Hvsen is entity of China. It is traded as Stock on SHE exchange.Things to note about Wuhan Hvsen Biotechnology performance evaluation
Checking the ongoing alerts about Wuhan Hvsen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Wuhan Hvsen Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Wuhan Hvsen generated a negative expected return over the last 90 days | |
| About 61.0% of the company shares are owned by insiders or employees |
- Analyzing Wuhan Hvsen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wuhan Hvsen's stock is overvalued or undervalued compared to its peers.
- Examining Wuhan Hvsen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wuhan Hvsen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wuhan Hvsen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wuhan Hvsen's stock. These opinions can provide insight into Wuhan Hvsen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Wuhan Stock analysis
When running Wuhan Hvsen's price analysis, check to measure Wuhan Hvsen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wuhan Hvsen is operating at the current time. Most of Wuhan Hvsen's value examination focuses on studying past and present price action to predict the probability of Wuhan Hvsen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wuhan Hvsen's price. Additionally, you may evaluate how the addition of Wuhan Hvsen to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |